{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:22:44Z","timestamp":1775197364987,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MSD Animal Health Innovation GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Broad-spectrum combination products with efficacy against endo- and ectoparasites offer the potential to optimize owner adherence to expert recommendations for canine antiparasitic treatments. In the development program for a chewable tablet containing fluralaner, moxidectin, and pyrantel, a non-terminal study design was implemented to determine anthelminthic efficacy. Four laboratory studies assessed the efficacy of this investigational veterinary product (IVP) against adult hookworms and adult\n                      <jats:italic>Toxascaris leonina<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In four single-site, non-terminal dose confirmation studies, dogs were inoculated with third-stage larvae of\n                      <jats:italic>Uncinaria stenocephala<\/jats:italic>\n                      (Studies 1 and 2),\n                      <jats:italic>Ancylostoma caninum<\/jats:italic>\n                      (Study 3), or larvated eggs of\n                      <jats:italic>T. leonina<\/jats:italic>\n                      (Study 4). Using fecal egg counts (FECs) from those infections, dogs were ranked and randomized to groups (Studies 1, 3, and 4, 10 per group; Study 2, 8 per group and treated once orally, on day 0, with the minimum recommended IVP dose (fluralaner 10\u00a0mg\/kg, moxidectin 0.025\u00a0mg\/kg, pyrantel 5\u00a0mg\/kg)\n                      <jats:bold>(<\/jats:bold>\n                      BRAVECTO\n                      <jats:sup>\u00ae<\/jats:sup>\n                      TriUNO, MSD), or left untreated. Approximately 2 weeks later, both groups in all studies were treated orally with a diagnostic dewormer (DDW) containing emodepside-praziquantel (Profender\n                      <jats:sup>\u00ae<\/jats:sup>\n                      modified-release Tablets for Dogs, Vetoquinol). The primary efficacy objective was determined by counts of expelled worms recovered after DDW treatment. Copro-antigen enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and FECs were completed at key time points.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Adequacy of infection was shown in all studies. Relative to the control groups, statistically significant reductions in mean worm counts were found in IVP-treated groups in Studies 1, 2, 3, and 4 (99.8%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001; 100%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0002; 100%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001; and 99.4%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001, respectively). All control dogs had positive FECs until the DDW treatment, while no eggs were detected after day 0 in 36 of the 38 IVP-treated dogs. Findings from copro-PCR and antigen-ELISA were consistent with and confirmatory of the conclusions from worm counts and FECs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A single, orally administered dose of this chewable tablet formulation is effective in treating canine infections with adult hookworms (\n                      <jats:italic>U. stenocephala<\/jats:italic>\n                      ,\n                      <jats:italic>A. caninum<\/jats:italic>\n                      ) and\n                      <jats:italic>T. leonina<\/jats:italic>\n                      . Non-terminal studies present a valid means of determining the efficacy of anthelmintic treatments for these canine intestinal parasites.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-07232-w","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:04:34Z","timestamp":1770138274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy evaluation of a new oral chewable tablet containing fluralaner, moxidectin, and pyrantel (BRAVECTO\u00ae TriUNO) against hookworm and Toxascaris leonina infections in a non-terminal study design in dogs"],"prefix":"10.1186","volume":"19","author":[{"given":"Lea","family":"Heinau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Rohdich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Plehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Chiummo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Zschiesche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luther","family":"van der Mescht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Liebenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"7232_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12917-023-03765-3","volume":"19","author":"S Illiano","year":"2023","unstructured":"Illiano S, Ciuca L, Maurelli MP, Pepe P, Caruso V, Bosco A, et al. Epidemiological and molecular updates on hookworm species in dogs from southern Italy. BMC Vet Res. 2023;19:204.","journal-title":"BMC Vet Res"},{"key":"7232_CR2","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP guideline 01: worm control in dogs and cats, 6th edition; 2021. https:\/\/www.esccap.org\/guidelines\/. Accessed 3 Mar, 2025."},{"key":"7232_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13071-022-05440-2","volume":"15","author":"J Drake","year":"2022","unstructured":"Drake J, Sweet S, Baxendale K, Hegarty E, Horr S, Friis H, et al. Detection of Giardia and helminths in Western Europe at local K9 (canine) sites (DOGWALKS study). Parasit Vectors. 2022;15:311.","journal-title":"Parasit Vectors"},{"key":"7232_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s13071-019-3828-6","volume":"12","author":"PD Jimenez Castro","year":"2019","unstructured":"Jimenez Castro PD, Howell SB, Schaefer JJ, Avramenko RW, Gilleard JS, Kaplan RM. Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat? Parasit Vectors. 2019;12:576.","journal-title":"Parasit Vectors"},{"key":"7232_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijpddr.2020.04.003","volume":"13","author":"PD Jimenez Castro","year":"2020","unstructured":"Jimenez Castro PD, Mansour A, Charles S, Hostetler J, Settje T, Kulke D, et al. Efficacy evaluation of anthelmintic products against an infection with the canine hookworm (Ancylostoma caninum) isolate Worthy 4.1F3P in dogs. Int J Parasitol Drugs Drug Resist. 2020;13:22\u20137.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7232_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpddr.2021.08.005","volume":"17","author":"PD Jimenez Castro","year":"2021","unstructured":"Jimenez Castro PD, Venkatesan A, Redman E, Chen R, Malatesta A, Huff H, et al. Multiple drug resistance in hookworms infecting greyhound dogs in the USA. Int J Parasitol Drugs Drug Resist. 2021;17:107\u201317.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7232_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2460\/javma.22.08.0377","volume":"261","author":"PD Jimenez Castro","year":"2022","unstructured":"Jimenez Castro PD, Durrence K, Durrence S, Gianechini LS, Collins J, Dunn K, et al. Multiple anthelmintic drug resistance in hookworms (Ancylostoma caninum) in a Labrador breeding and training kennel in Georgia, USA. J Am Vet Med Assoc. 2022;261:342\u20137.","journal-title":"J Am Vet Med Assoc"},{"key":"7232_CR8","volume":"84","author":"MD Evason","year":"2023","unstructured":"Evason MD, Weese JS, Polansky B, Leutenegger CM. Emergence of canine hookworm treatment resistance: novel detection of Ancylostoma caninum anthelmintic resistance markers by fecal PCR in 11 dogs from Canada. Am J Vet Res. 2023;84:ajvr.23.05.0116.","journal-title":"Am J Vet Res"},{"key":"7232_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijpddr.2021.07.003","volume":"17","author":"G von Samson-Himmelstjerna","year":"2021","unstructured":"von Samson-Himmelstjerna G, Thompson RA, Kr\u00fccken J, Grant W, Bowman DD, Schnyder M, et al. Spread of anthelmintic resistance in intestinal helminths of dogs and cats is currently less pronounced than in ruminants and horses\u2014yet it is of major concern. Int J Parasitol Drugs Drug Resist. 2021;17:36\u201345.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7232_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2025.100584","volume":"27","author":"PD Jimenez Castro","year":"2025","unstructured":"Jimenez Castro PD, Willcox JL, Rochani H, Richmond HL, Martinez HE, Lozoya CE, et al. Investigation of risk factors associated with Ancylostoma spp. infection and the benzimidazole F167Y resistance marker polymorphism in dogs from the United States. Int J Parasitol Drugs Drug Resist. 2025;27:100584.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7232_CR11","unstructured":"Companion Animal Parasite Council (CAPC). https:\/\/capcvet.org\/guidelines\/. Accessed 3 Mar 2025."},{"key":"7232_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13071-020-04086-2","volume":"13","author":"C Pennelegion","year":"2020","unstructured":"Pennelegion C, Drake J, Wiseman S, Wright I. Survey of UK pet owners quantifying internal parasite infection risk and deworming recommendation implications. Parasit Vectors. 2020;13:218.","journal-title":"Parasit Vectors"},{"key":"7232_CR13","volume":"10","author":"C Sherlock","year":"2023","unstructured":"Sherlock C, Holland CV, Keegan JD. Caring for canines: a survey of dog ownership and parasite control practices in Ireland. Vet Sci. 2023;10:90.","journal-title":"Vet Sci"},{"key":"7232_CR14","doi-asserted-by":"publisher","unstructured":"Maddison J, Cannon M, Davies R, Farquhar R, Faulkner B, Furtado T, et al. Owner compliance in veterinary practice: Recommendations from a roundtable discussion. https:\/\/www.magonlinelibrary.com\/doi\/full\/https:\/\/doi.org\/10.12968\/coan.2021.0029#. Accessed Mar 4, 2025.","DOI":"10.12968\/coan.2021.0029"},{"key":"7232_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13071-020-04147-6","volume":"13","author":"K Stafford","year":"2020","unstructured":"Stafford K, Kollasch TM, Duncan KT, Horr S, Goddu T, Heinz-Loomer C, et al. Detection of gastrointestinal parasitism at recreational canine sites in the USA: the DOGPARCS study. Parasit Vectors. 2020;13:275.","journal-title":"Parasit Vectors"},{"key":"7232_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pt.2017.09.002","volume":"34","author":"D Traversa","year":"2018","unstructured":"Traversa D, Joachim A. The 3Rs concept: time to change how we evaluate the efficacy of anthelmintics in companion animals. Trends Parasitol. 2018;34:41\u201352.","journal-title":"Trends Parasitol"},{"key":"7232_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2022.109815","volume":"312","author":"F Beugnet","year":"2022","unstructured":"Beugnet F, Taweethavonsawat P, Traversa D, Fourie J, McCall J, Tielemans E, et al. World Association for the Advancement of Veterinary Parasitology (WAAVP): second edition of guidelines for evaluating the efficacy of anthelmintics for dogs and cats. Vet Parasitol. 2022;312:109815.","journal-title":"Vet Parasitol"},{"key":"7232_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/1040638717706098","volume":"29","author":"DA Elsemore","year":"2017","unstructured":"Elsemore DA, Geng J, Cote J, Hanna R, Lucio-Forster A, Bowman DD. Enzyme-linked immunosorbent assays for coproantigen detection of Ancylostoma caninum and Toxocara canis in dogs and Toxocara cati in cats. J Vet Diagn Invest. 2017;29:645\u201353.","journal-title":"J Vet Diagn Invest"},{"key":"7232_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijpddr.2023.01.001","volume":"21","author":"CM Leutenegger","year":"2023","unstructured":"Leutenegger CM, Lozoya CE, Tereski J, Savard C, Ogeer J, Lallier R. Emergence of Ancylostoma caninum parasites with the benzimidazole resistance F167Y polymorphism in the US dog population. Int J Parasitol Drugs Drug Resist. 2023;21:131\u201340.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7232_CR20","volume":"105","author":"G Altreuther","year":"2009","unstructured":"Altreuther G, Radeloff I, LeSueur C, Schimmel A, Krieger KJ. Field evaluation of the efficacy and safety of emodepside plus praziquantel tablets (Profender\u00ae tablets for dogs) against naturally acquired nematode and cestode infections in dogs. Parasitol Res. 2009;105:S23-9.","journal-title":"Parasitol Res"},{"key":"7232_CR21","unstructured":"Tropical Council for Companion Animal Parasites (TROCCAP). https:\/\/www.troccap.com\/canine-guidelines. Accessed 25 Mar 2025."},{"key":"7232_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1040638714528500","volume":"26","author":"DA Elsemore","year":"2014","unstructured":"Elsemore DA, Geng J, Flynn L, Cruthers L, Lucio-Forster A, Bowman DD. Enzyme-linked immunosorbent assay for coproantigen detection of Trichuris vulpis in dogs. J Vet Diagn Invest. 2014;26:404\u201311.","journal-title":"J Vet Diagn Invest"},{"key":"7232_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/bs.apar.2020.01.034","volume":"109","author":"DA Elsemore","year":"2020","unstructured":"Elsemore DA. Antigen detection: Insights into Toxocara and other ascarid infections in dogs and cats. Adv Parasitol. 2020;109:545\u201359.","journal-title":"Adv Parasitol"},{"key":"7232_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.vetpar.2017.10.002","volume":"247","author":"C Adolph","year":"2017","unstructured":"Adolph C, Barnett S, Beall M, Drake J, Elsemore D, Thomas J, et al. Diagnostic strategies to reveal covert infections with intestinal helminths in dogs. Vet Parasitol. 2017;247:108\u201312.","journal-title":"Vet Parasitol"},{"key":"7232_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008392","volume":"14","author":"L Massetti","year":"2020","unstructured":"Massetti L, Colella V, Zendejas PA, Ng-Nguyen D, Harriott L, Marwedel L, et al. High-throughput multiplex qPCRs for the surveillance of zoonotic species of canine hookworms. PLoS Negl Trop Dis. 2020;14:e0008392.","journal-title":"PLoS Negl Trop Dis"},{"key":"7232_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13071-023-05904-z","volume":"16","author":"CM Leutenegger","year":"2023","unstructured":"Leutenegger CM, Lozoya CE, Tereski J, Andrews J, Mitchell KD, Meeks C, et al. Comparative study of a broad qPCR panel and centrifugal flotation for detection of gastrointestinal parasites in fecal samples from dogs and cats in the United States. Parasit Vectors. 2023;16:288.","journal-title":"Parasit Vectors"},{"key":"7232_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4269\/ajtmh.2007.77.685","volume":"77","author":"JJ Verweij","year":"2007","unstructured":"Verweij JJ, Brienen EA, Ziem J, Yelifari L, Polderman AM, Van Lieshout L. Simultaneous detection and quantification of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex real-time PCR. Am J Trop Med Hyg. 2007;77:685\u201390.","journal-title":"Am J Trop Med Hyg"},{"key":"7232_CR28","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4269\/ajtmh.18-0276","volume":"99","author":"SF Hii","year":"2018","unstructured":"Hii SF, Senevirathna D, Llewellyn S, Inpankaew T, Odermatt P, Khieu V, et al. Development and evaluation of a multiplex quantitative real-time polymerase chain reaction for hookworm species in human stool. Am J Trop Med Hyg. 2018;99:1186\u201393.","journal-title":"Am J Trop Med Hyg"},{"key":"7232_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007363","volume":"13","author":"K Stracke","year":"2019","unstructured":"Stracke K, Clarke N, Awburn CV, Vaz Nery S, Khieu V, Traub RJ, et al. Development and validation of a multiplexed-tandem qPCR tool for diagnostics of human soil-transmitted helminth infections. PLoS Negl Trop Dis. 2019;13:e0007363.","journal-title":"PLoS Negl Trop Dis"},{"key":"7232_CR30","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2460\/ajvr.1975.36.09.1387","volume":"36","author":"WD Lindquist","year":"1975","unstructured":"Lindquist WD. Drug evaluation of pyrantel pamoate against Ancylostoma, Toxocara, and Toxascaris in eleven dogs. Am J Vet Res. 1975;36:1387\u20139.","journal-title":"Am J Vet Res"},{"key":"7232_CR31","unstructured":"Nelson CT, McCall JW, Moorhead A, Starkey L, Ames M. American Heartworm Society: Canine guidelines for the prevention, diagnosis, and management of heartworm (Dirofilaria immitis) infection in dogs 2024. https:\/\/d3ft8sckhnqim2.cloudfront.net\/images\/AHS_Canine_Guidelinesweb05JUNE2024.pdf?1717702845. Accessed 30 Oct 2025."},{"key":"7232_CR32","unstructured":"EMA. Advocate spot-on solution for dogs. Summary of product characteristics. Advocate, INN-imidacloprid\/moxidectin."},{"key":"7232_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13071-020-3950-5","volume":"13","author":"C Becskei","year":"2020","unstructured":"Becskei C, Kryda K, Thys M, Holzmer S, Bowersock L, Fernandes T, et al. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced ascarid infections in dogs. Parasit Vectors. 2020;13:71.","journal-title":"Parasit Vectors"},{"key":"7232_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13071-025-06757-4","volume":"18","author":"S Charles","year":"2025","unstructured":"Charles S, Deuster K, Wang X, Wiseman S, Reinemeyer CR, van der Mescht L, et al. Efficacy of a novel chewable tablet (Credelio Quattro\u2122) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs. Parasit Vectors. 2025;18:125.","journal-title":"Parasit Vectors"},{"key":"7232_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13071-025-06968-9","volume":"18","author":"S Charles","year":"2025","unstructured":"Charles S, Wiseman S, Wang X, Savadelis MD, Reinemeyer CR, Bouzaidi Cheikhi I, et al. Efficacy of a novel chewable tablet (Credelio Quattro\u2122) containing lotilaner, moxidectin, praziquantel, and pyrantel against Toxocara canis and Toxascaris leonina infections in dogs. Parasit Vectors. 2025;18:356.","journal-title":"Parasit Vectors"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-07232-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07232-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07232-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T18:28:26Z","timestamp":1771352906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-025-07232-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7232"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-07232-w","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with EU Directive 2010\/63 as well as local and national regulations. The protocol was reviewed and approved by the Study Site Institutional Animal Care and Use Committee and by the Sponsor\u2019s ethics committee prior to implementation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LH, IP, NR, CP, and EZ are employees of MSD Animal Health Innovation GmbH, Schwabenheim, Germany. RC is an employee of MSD Sa\u00fade Animal, S\u00e3o Paulo, Brazil, and was an employee of MSD Animal Health Innovation GmbH, Schwabenheim, Germany at the time of study conduct. AB is an employee of Merck Animal Health, Rahway, New Jersey, USA. LM was and JL is employed by ClinVet International (pty) Ltd, Bainsvlei, Bloemfontein, Republic of South Africa, the contract research organization (CRO) which was commissioned by MSD Animal Health to conduct these studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}